FDA releases guidance on advisory panel disclosure

04/6/2014 | MassDevice.com (Boston)

The FDA has issued guidelines for participation on advisory panels for new drugs and devices. The guidelines require that prospective advisers disclose business relationships and permit the FDA to accept a consultant on a panel despite possible conflicts of interest.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ